Safety and efficacy assessment of two new leprosy skin test antigens: randomized double blind clinical study.
New tools are required for the diagnosis of pre-symptomatic leprosy towards further reduction of disease burden and its associated reactions. To address this need, two new skin test antigens were developed to assess safety and efficacy in human trials.A Phase I safety trial was first conducted in a...
Saved in:
Main Authors: | Becky L Rivoire (Author), Nathan A Groathouse (Author), Stephen TerLouw (Author), Kapil Dev Neupane (Author), Chaman Ranjit (Author), Bishwa Raj Sapkota (Author), Saraswoti Khadge (Author), Chhatra B Kunwar (Author), Murdo Macdonald (Author), Rachel Hawksworth (Author), Min B Thapa (Author), Deanna A Hagge (Author), Melinda Tibbals (Author), Carol Smith (Author), Tina Dube (Author), Dewei She (Author), Mark Wolff (Author), Eric Zhou (Author), Mamodikoe Makhene (Author), Robin Mason (Author), Christine Sizemore (Author), Patrick J Brennan (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2014-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The challenge of producing skin test antigens with minimal resources suitable for human application against a neglected tropical disease; leprosy.
by: Becky L Rivoire, et al.
Published: (2014) -
Diagnosis and treatment of leprosy reactions in integrated services--the patients' perspective in Nepal.
by: Sonia F Raffe, et al.
Published: (2013) -
Human beta-defensin 3 is up-regulated in cutaneous leprosy type 1 reactions.
by: Anna L Cogen, et al.
Published: (2012) -
Human TLR1 deficiency is associated with impaired mycobacterial signaling and protection from leprosy reversal reaction.
by: Elizabeth A Misch, et al.
Published: (2008) -
A phase two randomised controlled double blind trial of high dose intravenous methylprednisolone and oral prednisolone versus intravenous normal saline and oral prednisolone in individuals with leprosy type 1 reactions and/or nerve function impairment.
by: Stephen L Walker, et al.
Published: (2011)